Lv3
370 积分 2021-07-15 加入
Expert consensus opinion on the management of hairy cell leukemia in elderly patients
2个月前
已完结
Real-world treatment and outcomes in hairy cell leukemia: a multicenter retrospective cohort including BRAF inhibitor therapy
2个月前
已完结
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia
3个月前
已完结
Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy
6个月前
已完结
CAR T-cell Therapy for Central Nervous System Lymphoma
7个月前
已完结
Flow Cytometric MRD Detection in Selected Mature B-Cell Malignancies
7个月前
已完结
The role of MRD monitoring and options for CLL management in relapsed/refractory disease
7个月前
已关闭
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
8个月前
已完结
Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis
9个月前
已完结
Advances in the treatment of mantle cell lymphoma with BTK inhibitors
9个月前
已完结
皖公网安备34019202002308
